Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes (Q43867550)
Jump to navigation
Jump to search
scientific article published in February 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes |
scientific article published in February 2002 |
Statements
1 reference
Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes (English)
1 reference
1 reference
Claus B Juhl
1 reference
Malene Hollingdal
1 reference
Jeppe Sturis
1 reference
Grethe Jakobsen
1 reference
Henrik Agersø
1 reference
Niels Pørksen
1 reference
Ole Schmitz
1 reference
1 February 2002
1 reference
Identifiers
1 reference